FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1626349769> ?p ?o ?g. }

• W1626349769 endingPage "7248" @default.
• W1626349769 startingPage "7243" @default.
• W1626349769 abstract "Signal transducer and activator of transcription 3 (STAT3) had been involved in liver fibrogenesis. We aimed to explore the antifibrotic activities of sorafenib and its derivative SC-1 (devoid of Raf kinase inhibition activity) both in vivo and in vitro with special focus on the STAT3 pathway in hepatic stellate cells (HSCs). The clinical role of STAT3 in chronic hepatitis B (CHB) was also investigated. Experimental fibrosis mouse models were established by thioacetamide injection and bile duct ligation in Balb/C mice and treated with sorafenib and SC-1. Rat and human HSCs were used for mechanistic investigations. Forty CHB patients were enrolled to quantify the hepatic phospho-STAT3 (p-STAT3) levels and correlated with liver fibrosis. Both sorafenib and SC-1 ameliorated liver fibrosis in vivo and promoted HSC apoptosis in vitro. p-STAT3 and downstream signals were down-regulated after sorafenib and SC-1 treatment in HSC. STAT3 overexpression in HSC enhanced cell proliferation and undermined the apoptotic effects of sorafenib and SC-1, whereas STAT3-specific inhibition promoted HSC apoptosis. Sorafenib and SC-1 activated Src-homology protein tyrosine phosphatase-1 (SHP-1) and STAT3 inhibition followed. Of particular interest, in CHB patients with advanced liver fibrosis, p-STAT3 in HSC was significantly overexpressed and positively correlated with the severity of liver fibrosis and plasma IL-6 levels. In conclusion, sorafenib and SC-1 ameliorate liver fibrosis through STAT3 inhibition in HSC and STAT3 may potentially serve as a promising fibrotic biomarker and target in liver fibrosis. SHP-1 phosphatase-directed STAT3 inhibition may represent a previously unidentified strategy for antifibrotic drug discovery." @default.
• W1626349769 created "2016-06-24" @default.
• W1626349769 creator A5003451116 @default.
• W1626349769 creator A5005714550 @default.
• W1626349769 creator A5039644586 @default.
• W1626349769 creator A5039672232 @default.
• W1626349769 creator A5041457441 @default.
• W1626349769 creator A5058253583 @default.
• W1626349769 creator A5061524286 @default.
• W1626349769 creator A5063550464 @default.
• W1626349769 creator A5065054918 @default.
• W1626349769 creator A5067462259 @default.
• W1626349769 creator A5072593323 @default.
• W1626349769 creator A5079917695 @default.
• W1626349769 creator A5081855474 @default.
• W1626349769 creator A5082252498 @default.
• W1626349769 creator A5085573537 @default.
• W1626349769 date "2015-05-26" @default.
• W1626349769 modified "2023-10-18" @default.
• W1626349769 title "Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition" @default.
• W1626349769 cites W1967447165 @default.
• W1626349769 cites W1979161827 @default.
• W1626349769 cites W1986055077 @default.
• W1626349769 cites W1990057839 @default.
• W1626349769 cites W1993564425 @default.
• W1626349769 cites W1995428194 @default.
• W1626349769 cites W2009500547 @default.
• W1626349769 cites W2013568031 @default.
• W1626349769 cites W2022169488 @default.
• W1626349769 cites W2025949871 @default.
• W1626349769 cites W2032072777 @default.
• W1626349769 cites W2037038225 @default.
• W1626349769 cites W2037982488 @default.
• W1626349769 cites W2052467994 @default.
• W1626349769 cites W2054099223 @default.
• W1626349769 cites W2065902287 @default.
• W1626349769 cites W2067561369 @default.
• W1626349769 cites W2069643978 @default.
• W1626349769 cites W2071749269 @default.
• W1626349769 cites W2071840858 @default.
• W1626349769 cites W2099477838 @default.
• W1626349769 cites W2104193042 @default.
• W1626349769 cites W2112099875 @default.
• W1626349769 cites W2114994872 @default.
• W1626349769 cites W2116609639 @default.
• W1626349769 cites W2119117909 @default.
• W1626349769 cites W2121339421 @default.
• W1626349769 cites W2126159152 @default.
• W1626349769 cites W2140765540 @default.
• W1626349769 cites W2158089810 @default.
• W1626349769 cites W2160584487 @default.
• W1626349769 cites W2162226128 @default.
• W1626349769 cites W2162797083 @default.
• W1626349769 cites W4240582591 @default.
• W1626349769 doi "https://doi.org/10.1073/pnas.1507499112" @default.
• W1626349769 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4466718" @default.
• W1626349769 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26039995" @default.
• W1626349769 hasPublicationYear "2015" @default.
• W1626349769 type Work @default.
• W1626349769 sameAs 1626349769 @default.
• W1626349769 citedByCount "61" @default.
• W1626349769 countsByYear W16263497692015 @default.
• W1626349769 countsByYear W16263497692016 @default.
• W1626349769 countsByYear W16263497692017 @default.
• W1626349769 countsByYear W16263497692018 @default.
• W1626349769 countsByYear W16263497692019 @default.
• W1626349769 countsByYear W16263497692020 @default.
• W1626349769 countsByYear W16263497692021 @default.
• W1626349769 countsByYear W16263497692022 @default.
• W1626349769 countsByYear W16263497692023 @default.
• W1626349769 crossrefType "journal-article" @default.
• W1626349769 hasAuthorship W1626349769A5003451116 @default.
• W1626349769 hasAuthorship W1626349769A5005714550 @default.
• W1626349769 hasAuthorship W1626349769A5039644586 @default.
• W1626349769 hasAuthorship W1626349769A5039672232 @default.
• W1626349769 hasAuthorship W1626349769A5041457441 @default.
• W1626349769 hasAuthorship W1626349769A5058253583 @default.
• W1626349769 hasAuthorship W1626349769A5061524286 @default.
• W1626349769 hasAuthorship W1626349769A5063550464 @default.
• W1626349769 hasAuthorship W1626349769A5065054918 @default.
• W1626349769 hasAuthorship W1626349769A5067462259 @default.
• W1626349769 hasAuthorship W1626349769A5072593323 @default.
• W1626349769 hasAuthorship W1626349769A5079917695 @default.
• W1626349769 hasAuthorship W1626349769A5081855474 @default.
• W1626349769 hasAuthorship W1626349769A5082252498 @default.
• W1626349769 hasAuthorship W1626349769A5085573537 @default.
• W1626349769 hasBestOaLocation W16263497691 @default.
• W1626349769 hasConcept C142724271 @default.
• W1626349769 hasConcept C150903083 @default.
• W1626349769 hasConcept C171958077 @default.
• W1626349769 hasConcept C176891718 @default.
• W1626349769 hasConcept C185592680 @default.
• W1626349769 hasConcept C190283241 @default.
• W1626349769 hasConcept C207001950 @default.
• W1626349769 hasConcept C2778019345 @default.
• W1626349769 hasConcept C2778695046 @default.
• W1626349769 hasConcept C2778923194 @default.
• W1626349769 hasConcept C2780559512 @default.

• next